Knowledge, Attitude, and Practice (KAP) about the Risk Factors of Stroke in Isfahan, Iran

Document Type : Original Article(s)

Authors

1 Associate Professor, Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

2 ِDepartment of Epidemiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

3 Department of Health Education and Promotion, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.

4 Student of Medicine, Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Abstract

Background: Stroke is the third cause of death worldwide after cancers and cardiovascular disease. Many disabilities occurred after stroke. In the United States in each second one person suffer a stroke. Unfortunately there are no accurate statistics of the incidence of stroke. In this study we examined the knowledge, attitude, and practices (KAP) about risk factors for stroke in people referred to health centers in Isfahan.Methods: In this cross-sectional study 332 person who referred to health centers were evaluated. Sampling was done systematically and the data gathered by KAP questionnaire were analyzed using SPSS15.Results: Totally 332 person (144 men and 188 women) were enrolled in this study. The mean age of men and women were 42 ± 8.5 and 41/1 ± 7.3 respectively. The mean score of KAP about risk factors for stroke is 14.5 ± 1.6.Conclusion: In this study knowledge, attitude and practice about stroke risk factors was not desirable. Therefore the health system should plan to promote awareness about stroke in the community

Keywords

References

  1. Jacobsen BK, Heuch I, Kvale G. Age at natural menopause and stroke mortality: cohort study with 3561 stroke deaths during 37-year follow-up. Stroke 2004; 35(7): 1548-51.
  2. Murphy SJ, McCullough LD, Smith JM. Stroke in the female: role of biological sex and estrogen. ILAR J 2004; 45(2): 147-59.
  3. Jacobsen BK, Nilssen S, Heuch I, Kvale G. Does age at natural menopause affect mortality from ischemic heart disease? J Clin Epidemiol 1997; 50(4): 475-9.
  4. de Kleijn MJ, van der Schouw YT, Verbeek AL, Peeters PH, Banga JD, van der GY. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol 2002; 155(4): 339-45.
  5. Paganini-Hill A. Hormone replacement therapy and stroke: risk, protection or no effect? Maturitas 2001; 38(3): 243-61.
  6. Gibson CL, Gray LJ, Murphy SP, Bath PM. Estrogens and experimental ischemic stroke: a systematic review. J Cereb Blood Flow Metab 2006; 26(9): 1103-13.
  7. Li C, Engstrom G, Hedblad B, Berglund G, Janzon L. Risk of stroke and hormone replacement therapy. A prospective cohort study. Maturitas 2006; 54(1): 11-8.
  8. Henderson VW. Menopause and disorders of the central nervous system. Minerva Ginecol 2005; 57(6): 579-92.
  9. Yang SH, Liu R, Perez EJ, Wang X, Simpkins JW. Estrogens as protectants of the neurovascular unit against ischemic stroke. Curr Drug Targets CNS Neurol Disord 2005; 4(2): 169-77.
  10. Cohen PG. Estradiol induced inhibition of 11beta-hydroxysteroid dehydrogenase 1: an explanation for the postmenopausal hormone replacement therapy effects. Med Hypotheses 2005; 64(5): 989-91.
  11. Inoue N, Ichimura H, Goto S, Ushio Y. Cerebral thrombosis in a postmenopausal woman on HRT. J Clin Neurosci 2005; 12(1): 109-10.
  12. Simpkins JW, Yang SH, Liu R, Perez E, Cai ZY, Covey DF, et al. Estrogen-like compounds for ischemic neuroprotection. Stroke 2004; 35(11 Suppl 1): 2648-51.
Journal of Isfahan Medical School
Volume 29, Issue 137 - Serial Number 137
March and April 2011
Pages 495-504

Files

History

  • Receive Date: 29 June 2011
  • Revise Date: 20 May 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics